Innovative research on the etiology, pathogenesis and diagnosis and treatment of vascular dementia

Hubei University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. The age of the subjects was 35-85 years old;
•2. It was in accordance with the diagnostic standard of Western medicine for vascular dementia;
•3. It is in accordance with the diagnostic standard of TCM phlegm and blood stasis syndrome of vascular dementia;
•4. They signed informed consent and volunteered to participate in the study;
•5. The patients are expected to follow up within half a year.

•1. Early memory impairment with progressive deterioration, early prominent features of Parkinson's disease, and primary nervous system diseases (such as multiple sclerosis, encephalitis, etc.);
•2. There was no vascular lesion in neuroimaging examination;
•3. Other diseases that can explain cognitive impairment, such as brain tumor, multiple sclerosis,encephalitis, depression, poisoning, and systemic diseases and metabolic abnormalities that significantly affect cognitive function;
•4. Severe heart, brain, liver and hematopoiesis diseases, or other serious diseases affecting their survival;
•5. Drug or alcohol abuse / dependence within 3 months before participating in the trial;
•6. Pregnant and lactating women;
•7. Patients with severe mental disorders (perception disorders, thinking disorders);
•8. For known renal insufficiency, serum creatinine (CR) was higher than 221 umol/L in male and 177 umol/L in female;
•9. Patients with known liver dysfunction, alanine aminotransferase (ALT) > times of normal value or with cirrhosis;
•10. The researchers believe that there are other situations that are not suitable for participating in this study.

发起方

Hubei University of Chinese Medicine